PCM
PGNX

Piermont Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Piermont Capital Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-355,389
Closed -$1.55M – 298
2016
Q1 		$1.55M Sell
355,389
-8,160
-2% -$35.6K 0.49% 92
2015
Q4 		$2.23M Hold
363,549
– – 0.71% 67
2015
Q3 		$2.08M Buy
363,549
+12,855
+4% +$73.5K 0.68% 78
2015
Q2 		$2.62M Buy
+350,694
New +$2.62M 0.79% 63